Companion Diagnostics Market Scenario

Rising need for targeted therapy, technological advancements in the field of companion diagnostics and increasing importance of personalized medicine are some of the major factors propelling the companion diagnostics market globally. Furthermore, growing burden of infectious diseases is also one of the factor propelling the growth of companion diagnostics market. However, high cost of companion diagnostic tests is one of the major factor expected to hamper the global growth of the market.

Companion Diagnostics Market Segmentation

The Companion Diagnostics market is segmented by Products & Services, Technology, Indication, End User and Geography. The Products & Services studied in the report are Assay kits & Reagents and Software & Services. Furthermore, the Technology comprises of Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Next-Generation Sequencing (NGS), Immunohistochemistry (IHC) and others. Moreover, the Indication include Cardiovascular, Neurological Diseases, Cancer (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma and Gastric Cancer), Infectious Diseases and Others. In addition, various End Users of companion diagnostics market are Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, CROs and Others. Based on Geography, the Companion Diagnostics Market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW.

Companion Diagnostics Market by Geography

Based on geography, the Companion Diagnostics market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW. Among all the regions, the North America is anticipated to hold the major share of the global Companion Diagnostics market. Major drivers include high adoption of advanced techniques and diagnostic tools, higher healthcare expenditure, and availability of skilled professionals. U.S. holds the largest market share owing to factors such as highly developed healthcare infrastructure and availability of skilled professionals.

Companion Diagnostics Market Key Players

Some of the major players operating in the global Companion Diagnostics market includes F. Hoffmann-La Roche Ag, Agilent Technologies, Inc., Qiagen N.V., Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., Almac Group, Danaher Corporation, Illumina Inc., Biomérieux Sa, Myriad Genetics, Inc., Sysmex Corporation, Abnova Corporation, Guardant Health, Inc., Icon Plc and Biogenex Laboratories, Inc. Many companies in this market implement initiatives such as mergers and acquisitions, product developments, and geographic penetration to compete in the market.

Companion Diagnostics Market Report Key Benefits

• The report offers changing market dynamics in the Companion Diagnostics market, presenting historical, current and projected market size in terms of value (USD Million)
• The report comprises a detailed analysis of the factors that drive and restrict the growth of global Companion Diagnostics market.
• The research study provides an in-depth analysis of the industry value chain focusing on the peer and parent markets of Companion Diagnostics
• It presents a comprehensive assessment of geographical regions exhibiting promising growth, potential and niche segments, and a neutral perspective on the Companion Diagnostics market performance
• Key players within the global Companion Diagnostics market are profiled to understand the competitor scenario.

Research Objectives of Companion Diagnostics Market Report:

• Analysing the outlook of the market with the recent trends and Porter’s five forces analysis.
• Market dynamics, which essentially consider the factors that are impelling the present market scenario, along with growth prospects of the market over the forecast period.
• Market segmentation analysis, including qualitative and quantitative research, incorporating the impact of economic and non-economic aspects.
• Country-level analysis, integrating the demand and supply forces that are influencing the growth of the Companion Diagnostics market.
• Competitive landscape involving the market share of major players, along with the key strategies adopted for development over the past five years.
• Comprehensive company profiles, covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players.